Dergiler / Turkish journal of nephrology (Online) / 2022 / Cilt: 31 - Sayı: 1

Should We Weigh More on Home Dialysis Methods During Pandemic Periods: One Center Experience

Sayfa
27–32
Yayın Tarihi
2022-11-06
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The number of critical comorbidities appeared as the only significant variable in explaining the development of COVID-19 (P = .0569

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: This study aims to determine the difference in the coronavirus disease 2019 incidence between our patient group performing home dialysis, including home hemodialysis and peritoneal dialysis, and our patient group performing in-center hemodialysis.
📊
Temel Bulgular & Veri:Methods: The study consists of the patients followed up in our center: 58 scheduled hemodialysis, 9 home hemodialysis, and 54 peritoneal dialysis patients.
💡
Sonuç & Katkı:The number of critical comorbidities appeared as the only significant variable in explaining the development of COVID-19 (P = .0569
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: This study aims to determine the difference in the coronavirus disease 2019 incidence between our patient group performing home dialysis, including home hemodialysis and peritoneal dialysis, and our patient group performing in-center hemodialysis. Methods: The study consists of the patients followed up in our center: 58 scheduled hemodialysis, 9 home hemodialysis, and 54 peritoneal dialysis patients. All the patients were closely followed for the coronavirus disease 2019 symptoms between March 2020 and May 2020. The follow-up intervals of our patients who underwent peritoneal dialysis and home hemodialysis were increased from 1 month to 2 months; all of them were contacted over the phone at the beginning of the pandemic and 2 months later, and the patients were questioned in terms of the coronavirus disease 2019 symptoms. Relevant descriptive statistics were presented. Binary logistic regression model was applied to compare the development of coronavirus disease 2019 in the patient group who performed home dialysis (home hemodialysis and peritoneal dialysis) and in the patient group who performed in-center hemodialysis via the glm function in R that fits generalized linear models. Age and the number of critical comorbidities (diabetes mellitus, hypertension, coronary artery disease, congestive heart failure, and chronic obstructive lung disease) were employed as the other independent variables in the model. Results: Three of the 58 patients who underwent dialysis in our center were followed up in our pandemic service with the diagnosis of coronavirus disease 2019. Coronavirus disease 2019 positivity was not detected in any patient who applied dialysis methods at home. The number of critical comorbidities appeared as the only significant variable in explaining the development of COVID-19 (P = .0569

🔖

Bu Makaleye Atıf Yap

ÇANKAYA, E., AYPAK, A., DEDE, F., CEVHER, Ş. K., YENİGÜN, E. C., AKTÜRK, S., LEVENT, M. (2022). Should We Weigh More on Home Dialysis Methods During Pandemic Periods: One Center Experience. Turkish journal of nephrology (Online), Cilt: 31 - Sayı: 1, 27–32. https://ajindex.com/articles/612827

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Basile C, Combe C, Pizzarelli F, et al. Recommendations for the prevention, mitigation and containment of the emerging SARSCoV-2 (COVID-19) pandemic in haemodialysis centres. Nephrol Dial Transplant. 2020
  2. 35(5):737-741. [CrossRef] 2. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020
  3. 395(10223):507- 513. [CrossRef] 3. Koksal Cevher S. [Dataset] “Home dialysis in COVID-19 pandemic”, V1. Mendeley Data. 2020. [CrossRef] 4. Kliger AS, Silberzweig J. Mitigating risk of COVID-19 in dialysis facilities. Clin J Am Soc Nephrol. 2020
  4. 15(5):707-709. [CrossRef] 5. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020
  5. 395(10223):497-506. [CrossRef] 6. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020
  6. 382(18):1708-1720. [CrossRef] 7. Meijers B, Messa P, Ronco C. Safeguarding the maintenance hemodialysis patient population during the coronavirus disease 19 pandemic. Blood Purif. 2020
  7. 49(3):259-264. [CrossRef] 8. Syed-Ahmed M, Narayanan M. Immune dysfunction and risk of infection in chronic kidney disease. Adv Chronic Kidney Dis. 2019
  8. 26(1):8-15. [CrossRef] 9. Li J, Xu G. Lessons from the experience in Wuhan to reduce risk of COVID-19 infection in patients undergoing long-term hemodialysis. Clin J Am Soc Nephrol. 2020
  9. 15(5):717-719. [CrossRef] 10. Rombolà G, Heidempergher M, Pedrini L, et al. Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy. J Nephrol. 2020
  10. 33(2):193-196. [CrossRef] 11. Cozzolino M, Piccoli GB, Ikizler TA, Ronco C. The COVID-19 infection in dialysis: are home-based renal replacement therapies a way to improve patient management? J Nephrol. 2020
  11. 33(4):629- 631. [CrossRef] 12. Sachdeva M, Uppal NN, Hirsch JS, et al. COVID-19 in hospitalized patients on chronic peritoneal dialysis: a case series. Am J Nephrol. 2020
  12. 51(8):669-674. [CrossRef] 13. Valeri AM, Robbins-Juarez SY, Stevens JS, et al. Presentation and outcomes of patients with ESKD and COVID-19. J Am Soc Nephrol. 2020
  13. 31(7):1409-1415. [CrossRef] 14. Hager D, Ferguson TW, Komenda P. Cost controversies of a “home dialysis first” policy. Can J Kidney Health Dis. 2019
  14. 2054358119871541. [CrossRef] 15. National Nephrology, Dialys